MoneyWorks4Me

Natco Pharma reports 24% rise in Q3 consolidated net profit

10 Feb 2012 Evaluate

Natco Pharma has reported a 23.91% increase in its consolidated net profit at Rs 17 crore for the quarter ended December 31, 2011. The company had posted a net profit of Rs 13.72 crore in the same period of the last financial year.

The consolidated total income during the third quarter also went up by 22.89% to Rs 145.43 crore from Rs 118.34 crore in the year-ago period.

The board of directors also declared an interim dividend of Rs 3 per equity share of Rs 10 each for 2011-2012.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..